ctrl K

Price Alert

Verve Therapeutics Inc. (VERV)

NASDAQ: VERV · Real-Time Price · USD

11.13

0.03 (0.27%)

At close: Jul 24, 2025, 3:59 PM

Verve Therapeutics Revenue Breakdown

Period Ending	Mar 31, 2025
Operating Segments Revenue	32.98M
Operating Segments Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Selling, General, and Administrative Revenue	15.15M	14.1M	13.84M	14.55M	14.16M	12.28M	11.69M	13.42M	12.55M	11.44M	9.59M	9.07M	7.43M	6.6M	6.01M	3.54M	2.72M	2.02M	1.35M	1.03M	846K
Selling, General, and Administrative Revenue Growth	+7.48%	+1.89%	-4.88%	+2.71%	+15.32%	+5.09%	-12.90%	+6.87%	+9.75%	+19.25%	+5.79%	+21.95%	+12.63%	+9.89%	+69.64%	+30.38%	+34.19%	+49.48%	+31.20%	+21.99%	n/a
Research and Development Revenue	54.46M	55.05M	49.94M	50.98M	48.38M	46.81M	43.77M	47.26M	47.11M	37.28M	35.2M	33.13M	24.49M	25.94M	17.5M	13.42M	11.35M	15.58M	7.62M	5.65M	6.52M
Research and Development Revenue Growth	-1.07%	+10.23%	-2.05%	+5.39%	+3.34%	+6.96%	-7.40%	+0.32%	+26.35%	+5.93%	+6.26%	+35.26%	-5.59%	+48.27%	+30.34%	+18.32%	-27.16%	+104.46%	+34.74%	-13.32%	n/a